CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-23 | Resnick Joshua Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-23 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-06 | Attar Eyal C. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −999 | $1.75 | $2K | 110,708 |
| 2024-05-06 | Jorgensen Nathan D. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −834 | $1.75 | $1K | 189,403 |
| 2024-05-06 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −875 | $1.75 | $2K | 179,233 |
| 2024-05-06 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −2,361 | $1.75 | $4K | 810,368 |
| 2024-05-01 | Attar Eyal C. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,146 | $1.77 | $2K | 111,707 |
| 2024-05-01 | Jorgensen Nathan D. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −917 | $1.77 | $2K | 190,237 |
| 2024-05-01 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −985 | $1.77 | $2K | 180,108 |
| 2024-05-01 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −2,751 | $1.77 | $5K | 812,729 |
| 2024-04-30 | Namouni Fouad Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-03-01 | Jorgensen Nathan D. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −6,310 | $2.27 | $14K | 191,154 |
| 2024-03-01 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −5,576 | $2.27 | $13K | 181,093 |
| 2024-03-01 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −12,657 | $2.27 | $29K | 815,480 |
| 2024-02-06 | Attar Eyal C. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,180 | $2.32 | $3K | 112,853 |
| 2024-02-06 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −2,788 | $2.32 | $6K | 828,137 |
| 2024-02-06 | Jorgensen Nathan D. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −985 | $2.32 | $2K | 197,464 |
| 2024-02-06 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −1,033 | $2.32 | $2K | 186,669 |
| 2024-01-29 | Attar Eyal C. CHIEF MEDICAL OFFICER | Grant or award | +62,500 | 114,033 | ||
| 2024-01-29 | Attar Eyal C. CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 |
Page 12 of 18 · 344 trades